(Q44555719)

4 December 2017

title

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment (English)

1 reference

4 December 2017

1 reference

C Cantalloube

1

1 reference

4 December 2017

V Bhargava

2

1 reference

4 December 2017

E Sultan

3

1 reference

4 December 2017

F Vacheron

4

1 reference

4 December 2017

I Batista

5

1 reference

4 December 2017

G Montay

6

1 reference

4 December 2017

publication date

1 August 2003

1 reference

International Journal of Antimicrobial Agents

4 December 2017

published in

1 reference

4 December 2017

volume

22

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

112-121

1 reference

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900128-6

7 January 2021

10.1016/S0924-8579(03)00128-6

Identifiers

DOI

1 reference

4 December 2017

1 reference